{"id":"W2280334572","doi":"10.1016/s1474-4422(15)00393-2","title":"MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines","year":2016,"lang":"en","type":"review","venue":"The Lancet Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":863,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Chugai Pharmaceutical; European Commission; Sanofi; Bayer HealthCare; McGill University; Eli Lilly and Company; CSL Behring; Medical Research Council; Biogen; Pfizer; Teva Pharmaceutical Industries; National Institutes of Health; Siemens; National Research Foundation","keywords":"Multiple sclerosis; Medicine; Magnetic resonance imaging; Spinal cord; Medical physics; Disease; Clinically isolated syndrome; Expert opinion; Radiology; Pathology; Intensive care medicine; Psychiatry","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}